(To see other currencies, click on price)
MORE ABOUT THIS BOOK
Main description:
The induction of immune responses against tumor cells by vaccination is rapidly evolving as a therapeutic modality with new potentials for the treatment of cancer. It is based on the fact that our immune system can identify tumor cells and, once activated, is capable of developing specific immunity against the neoplastic cells. Numerous observations and intense research clearly document the major contribution of the immune system to the prevention of cancer. And there are many re ports of patients suffering from malignant melanoma or other tumors who mount a spontaneous immune response against their tumor cells that results in tumor regression. Based on the recent advances in our understanding of the compo nents of our immune system, their interactions and the regulation of immune responses, we are now able to design vaccination strategies that induce or enhance cell-mediated immunity against tumors. A ma jor advancement came with the identification and characterization of relevant tumor antigens, which are suitable target structures for anti-tu mor immune response. First clinical trials using such vaccine strategies have yielded encouraging results in patients. However, in spite of many reported cases of successful therapy of cancer by vaccination many patients still do not experience relief after such treatments. These initial clinical trials and the accompanying investigations have revealed a number of important results that indicate the direction of future re search and development in the field.
Contents:
1 Vaccination Therapy for Malignant Disease: The Clinical Perspective.- 2 Tumor Antigens.- 3 Costimulatory Molecules in Vaccine Design.- 4 Application of T Cell Immunotherapy for Human Viral and Malignant Diseases.- 5 Immune Monitoring in Cancer Immunotherapy.- 6 Retroviral Vectors for Cancer Gene Therapy.- 7 CpG Oligonucleotides as Immune Adjuvants.- 8 DNA Vaccination Against Cancer Antigens.- 9 Skin Cancer - Prospects for Novel Therapeutic Approaches.- 10 The Hybrid Cell Vaccination Approach to Cancer Immunotherapy.- 11 T Cell Receptor Peptides for the Vaccination Therapy of Multiple Sclerosis.- 12 Regulatory Aspects of Cancer Gene Therapy and DNA Vaccination.- Previous Volumes Published in this Series.
PRODUCT DETAILS
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Publication date: December, 2012
Pages: 195
Weight: 283g
Availability: Available
Subcategories: Dermatology, General Issues, Immunology, Oncology, Pharmacology
From the same series
Harald Renz
Alexei Bogdanov
W Wohlleben
P.H. Seeberger
P.A. Schubiger
Bernhard Haendler
Eugene Butcher
Kenneth S. Korach
Shelley L. Berger
H. Graf
John Morser
Heinz-Peter Schultheiss
Andreas Radbruch
S. Bernhard
R. Krattenmacher
Lechoslaw Turski
R.B. Lichtner
H. Graf
Ulrich Dirnagl
I. Schlichting
Kristof Chwalisz
A. Rosenthal
Richard Horuk
Khusru Asadullah
Hinrich Gronemeyer
J. Lindenmann
Eberhard Nieschlag
Robert E. Sobol
U.-F. Habenicht
Markus Schwaiger
R.G.G. Russell
F. Diederich
H. Seidel
Herbert Waldmann
H. Kettenmann
J.A. Dormandy
O. Pelkonen
V. Hansson
Martin Tenniswood
K. Beyreuther
Peter H. Seeburg
C.N. Serhan
C. Bezold
Jack R. Jr. Lancaster
A. Haverich
Kenneth S. Korach
C. Nüsslein-Volhard
John Eppig
Reinhard Ziegler
E.C. Herrmann
Erwin F. Wagner
A. Cockburn
Peter Ramwell
Orla M. Conneely
Guido Kroemer
Burkhart Schraven
Bernhard Haendler
Manfred T. Reetz
Bernhard Haendler
Guido Kroemer
Stefan Jaroch
Orla M. Conneely
Burkhart Schraven
Bernhard Haendler
Andreas Radbruch
P.H. Seeberger
Kenneth S. Korach
B. Weiss
P.A. Schubiger
John Morser
Stefan Jaroch
Shelley L. Berger